Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA2 NSD1 JMJD1C HR	5.34e-05	34	122	4	GO:0046966
GeneOntologyMolecularFunction	bisphosphoglycerate mutase activity	PGAM1 PGAM4	2.20e-04	4	122	2	GO:0004082
GeneOntologyMolecularFunction	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity	PGAM1 PGAM4	2.20e-04	4	122	2	GO:0046538
GeneOntologyMolecularFunction	phosphoglycerate mutase activity	PGAM1 PGAM4	2.20e-04	4	122	2	GO:0004619
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor activity	HTR2A CHRM2 CHRM5	3.15e-04	22	122	3	GO:0004993
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NRIP1 NSD1	3.60e-04	23	122	3	GO:0046965
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	CHRM5 GLRA2	5.47e-04	6	122	2	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	CHRM5 GLRA2	5.47e-04	6	122	2	GO:0016934
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA2 ZNF410 IRF2BP2 NRIP1 SGTB ANK3 NSD1 DUSP19 JMJD1C PEX26 JARID2 CD3E AKAP9 BRCA1 TRAT1 LIAT1 SMARCC2 TP53BP1 HR	5.65e-04	1356	122	19	GO:0060090
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA2 ZNF410 IRF2BP2 NRIP1 ANK3 NSD1 DUSP19 JMJD1C PEX26 JARID2 CD3E BRCA1 TRAT1 LIAT1 SMARCC2 TP53BP1 HR	6.89e-04	1160	122	17	GO:0030674
GeneOntologyMolecularFunction	ubiquitin-modified histone reader activity	JARID2 TP53BP1	7.62e-04	7	122	2	GO:0061649
GeneOntologyMolecularFunction	G protein-coupled acetylcholine receptor activity	CHRM2 CHRM5	7.62e-04	7	122	2	GO:0016907
GeneOntologyMolecularFunction	histone demethylase activity	JMJD1C JARID2 HR	8.83e-04	31	122	3	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	JMJD1C JARID2 HR	9.70e-04	32	122	3	GO:0140457
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	CHRM5 GLRA2	1.01e-03	8	122	2	GO:0005237
GeneOntologyCellularComponent	DNA repair complex	BRCA1 BRCA2 FANCI TP53BP1	9.27e-06	23	123	4	GO:1990391
GeneOntologyCellularComponent	lateral element	MEI4 BRCA1 BRCA2	1.80e-04	19	123	3	GO:0000800
HumanPheno	Diagnostic behavioral phenotype	HTR2A ANK3 ATRX CASP2 NSD1 UBA2 CHD8 REV3L NSUN2 JMJD1C ITPR1 JARID2 NDUFAF1 TMTC3 GLRA2 GLS SMARCC2 ATP2B1	9.12e-07	747	37	18	HP:0025783
HumanPheno	Autistic behavior	ANK3 ATRX CASP2 NSD1 UBA2 CHD8 REV3L NSUN2 JMJD1C ITPR1 JARID2 NDUFAF1 TMTC3 GLRA2 GLS SMARCC2 ATP2B1	1.26e-06	678	37	17	HP:0000729
HumanPheno	Toe syndactyly	NSD1 UBA2 NSUN2 ITPR1 JARID2 NEK1 BRCA1 BRCA2 FANCI	4.38e-05	244	37	9	HP:0001770
HumanPheno	Thin scalp hair	DSC3 ATRX NSD1 UBA2 NSUN2 SMARCC2 HR	6.03e-05	143	37	7	HP:0002556
HumanPheno	Thin hair	DSC3 ATRX NSD1 UBA2 NSUN2 SMARCC2 HR	6.03e-05	143	37	7	HP:0002237
HumanPheno	Sparse scalp hair	DSC3 ATRX NSD1 UBA2 NSUN2 SMARCC2 HR	6.03e-05	143	37	7	HP:0002209
HumanPheno	Abnormal preputium morphology	NSD1 BRCA1 BRCA2 FANCI	1.18e-04	36	37	4	HP:0100587
Domain	Phosphogly_mut1	PGAM1 PGAM4	2.32e-04	4	117	2	IPR005952
Domain	ZINC_FINGER_C2H2_2	ZNF410 PEG3 ZNF223 CPXCR1 ZNF230 ZNF836 ZNF394 ZNF608 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	3.50e-04	775	117	14	PS50157
Domain	Musac_Ach_rcpt	CHRM2 CHRM5	3.84e-04	5	117	2	IPR000995
Domain	KRAB	ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF846 ZNF483 ZNF616 ZNF81	4.24e-04	358	117	9	PS50805
Domain	KRAB	ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF846 ZNF483 ZNF616 ZNF81	4.24e-04	358	117	9	PF01352
Domain	JmjC	JMJD1C JARID2 HR	4.41e-04	24	117	3	PF02373
Domain	Znf_C2H2-like	ZNF410 PEG3 ZNF223 CPXCR1 ZNF230 ZNF836 ZNF394 ZNF608 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	4.57e-04	796	117	14	IPR015880
Domain	Znf_C2H2	ZNF410 PEG3 ZNF223 CPXCR1 ZNF230 ZNF836 ZNF394 ZNF608 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	5.11e-04	805	117	14	IPR007087
Domain	KRAB	ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF846 ZNF483 ZNF616 ZNF81	5.27e-04	369	117	9	SM00349
Domain	ZnF_C2H2	ZNF410 PEG3 ZNF223 CPXCR1 ZNF230 ZNF836 ZNF394 ZNF608 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	5.30e-04	808	117	14	SM00355
Domain	KRAB	ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF846 ZNF483 ZNF616 ZNF81	5.38e-04	370	117	9	IPR001909
Domain	BRCT_dom	BRCA1 SMARCC2 TP53BP1	7.00e-04	28	117	3	IPR001357
Domain	JMJC	JMJD1C JARID2 HR	1.04e-03	32	117	3	PS51184
Domain	JmjC_dom	JMJD1C JARID2 HR	1.04e-03	32	117	3	IPR003347
Domain	-	ZNF410 PEG3 ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	1.14e-03	679	117	12	3.30.160.60
Domain	JmjC	JMJD1C JARID2 HR	1.14e-03	33	117	3	SM00558
Domain	ZINC_FINGER_C2H2_1	ZNF410 PEG3 ZNF223 ZNF230 ZNF836 ZNF394 ZNF608 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	1.16e-03	777	117	13	PS00028
Domain	zf-C2H2	ZNF410 PEG3 ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	1.35e-03	693	117	12	PF00096
Domain	PG/BPGM_mutase_AS	PGAM1 PGAM4	1.36e-03	9	117	2	IPR001345
Domain	Znf_C2H2/integrase_DNA-bd	ZNF410 PEG3 ZNF223 ZNF230 ZNF836 ZNF394 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	1.37e-03	694	117	12	IPR013087
Domain	PGAM	PGAM1 PGAM4	1.69e-03	10	117	2	SM00855
Domain	PG_MUTASE	PGAM1 PGAM4	1.69e-03	10	117	2	PS00175
Domain	His_Pase_superF_clade-1	PGAM1 PGAM4	2.46e-03	12	117	2	IPR013078
Domain	His_Phos_1	PGAM1 PGAM4	2.46e-03	12	117	2	PF00300
Domain	TPR_1	SGTB CNOT10 TMTC3 WDTC1	2.47e-03	90	117	4	IPR001440
Domain	TPR_1	SGTB CNOT10 TMTC3 WDTC1	2.47e-03	90	117	4	PF00515
Domain	Ank	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	3.15e-03	228	117	6	PF00023
Domain	-	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	4.74e-03	248	117	6	1.25.40.20
Domain	LRR_6	TCTE1 CARMIL1 FBXL17	4.96e-03	55	117	3	PF13516
Domain	ANK	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	5.02e-03	251	117	6	SM00248
Domain	ANK_REPEAT	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	5.22e-03	253	117	6	PS50088
Domain	SCAN	PEG3 ZNF394 ZNF483	5.22e-03	56	117	3	SM00431
Domain	Ankyrin_rpt-contain_dom	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	5.31e-03	254	117	6	IPR020683
Domain	ANK_REP_REGION	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	5.31e-03	254	117	6	PS50297
Domain	SCAN_BOX	PEG3 ZNF394 ZNF483	5.75e-03	58	117	3	PS50804
Domain	SCAN	PEG3 ZNF394 ZNF483	5.75e-03	58	117	3	PF02023
Domain	SCAN_dom	PEG3 ZNF394 ZNF483	5.75e-03	58	117	3	IPR003309
Domain	Retrov_capsid_C	PEG3 ZNF394 ZNF483	6.04e-03	59	117	3	IPR008916
Domain	Ankyrin_rpt	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	6.16e-03	262	117	6	IPR002110
Domain	BRCT	BRCA1 TP53BP1	6.21e-03	19	117	2	PF00533
Pubmed	53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice.	BRCA1 BRCA2 TP53BP1	4.64e-08	3	126	3	32139898
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	NSD1 NSUN2 JMJD1C HNRNPAB NPTN BRCA1 BRCA2 ZNF827 FANCI SMARCC2 ATP2B1 TP53BP1	1.05e-07	453	126	12	29656893
Pubmed	Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.	BRCA1 BRCA2 TP53BP1	4.62e-07	5	126	3	38244928
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 ANK3 RBBP6 BAG3 NSD1 CHD8 JMJD1C ESF1 CEP170 NEK1 PLS3 TP53BP1	8.10e-07	549	126	12	38280479
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	LINC00322 ANK3 RBBP6 UBR4 BAG3 HMGN2 PNISR JMJD1C CEP170 ZNF616	8.50e-07	361	126	10	26167880
Pubmed	BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.	ATRX BRCA1 BRCA2	9.21e-07	6	126	3	28976962
Pubmed	BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks.	BRCA1 BRCA2 TP53BP1	9.21e-07	6	126	3	38554279
Pubmed	BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.	BRCA1 BRCA2 TP53BP1	3.84e-06	9	126	3	30704900
Pubmed	Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.	BRCA1 BRCA2 TP53BP1	3.84e-06	9	126	3	23657012
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	IRF2BP2 NRIP1 RBBP6 JMJD1C SBSN CEP170 FBN1	5.14e-06	184	126	7	32908313
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CDCA3 FAM184A ANK3 DSC3 ATRX UBR4 BAG3 ESF1 ITPR1 AKAP9 NDUFAF1 TMTC3 GLS LRRC1 MAP7D2 ATP2B1 PLS3 TP53BP1	7.18e-06	1487	126	18	33957083
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NRIP1 JMJD1C	7.50e-06	11	126	3	36613751
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	IRF2BP2 ATRX RBBP6 CARMIL1 BAG3 HMGN2 NSUN2 HNRNPAB ESF1 CEP170 NEK1 PRR14L TP53BP1 PARP12	7.85e-06	934	126	14	33916271
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	UBR4 DUSP19 PGAM1 NSUN2 CEP43 NDUFAF1 FANCI LRRC1 PRR14L HEATR5B ATP2B1	8.13e-06	573	126	11	28330616
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATRX RBBP6 NSD1 HMGN2 CHD8 JMJD1C HNRNPAB ESF1 CEP170 BRCA1 BRCA2 FANCI SMARCC2 TP53BP1	9.95e-06	954	126	14	36373674
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	REV3L BRCA1 TP53BP1	9.97e-06	12	126	3	28700933
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 EEFSEC IRF2BP2 UBA2 HMGN2 CHD8 PGAM1 NSUN2 JMJD1C HNRNPAB CEP170 BRCA1 FANCI SMARCC2 TP53BP1	1.16e-05	1103	126	15	34189442
Pubmed	Identification of proteins that interact with the central coiled-coil region of the human protein kinase NEK1.	ATRX NEK1 TP53BP1	1.29e-05	13	126	3	14690447
Pubmed	The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break Repair.	BRCA1 BRCA2 TP53BP1	1.29e-05	13	126	3	29499138
Pubmed	Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.	BRCA1 BRCA2	1.30e-05	2	126	2	29480828
Pubmed	A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.	BRCA1 BRCA2	1.30e-05	2	126	2	17924331
Pubmed	Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.	BRCA1 BRCA2	1.30e-05	2	126	2	12833555
Pubmed	Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.	BRCA1 BRCA2	1.30e-05	2	126	2	14735173
Pubmed	Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.30e-05	2	126	2	16032702
Pubmed	Oral contraceptive use and BRCA penetrance: a case-only study.	BRCA1 BRCA2	1.30e-05	2	126	2	19549808
Pubmed	Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.	BRCA1 BRCA2	1.30e-05	2	126	2	34101484
Pubmed	Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.	BRCA1 BRCA2	1.30e-05	2	126	2	26961146
Pubmed	Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study.	BRCA1 BRCA2	1.30e-05	2	126	2	20512419
Pubmed	Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.	BRCA1 BRCA2	1.30e-05	2	126	2	37804357
Pubmed	Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.	BRCA1 BRCA2	1.30e-05	2	126	2	22053997
Pubmed	BRCA mutations in women with inflammatory breast cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	29044548
Pubmed	Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.	BRCA1 BRCA2	1.30e-05	2	126	2	33834176
Pubmed	Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.	BRCA1 BRCA2	1.30e-05	2	126	2	18200524
Pubmed	Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.	BRCA1 BRCA2	1.30e-05	2	126	2	29298688
Pubmed	Fertility in women with BRCA mutations: a case-control study.	BRCA1 BRCA2	1.30e-05	2	126	2	19200971
Pubmed	Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.	BRCA1 BRCA2	1.30e-05	2	126	2	16030099
Pubmed	Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.	BRCA1 BRCA2	1.30e-05	2	126	2	28212807
Pubmed	Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	11448436
Pubmed	Rapid evolution of BRCA1 and BRCA2 in humans and other primates.	BRCA1 BRCA2	1.30e-05	2	126	2	25011685
Pubmed	Breast magnetic resonance imaging for screening high-risk women.	BRCA1 BRCA2	1.30e-05	2	126	2	23928241
Pubmed	Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	35980168
Pubmed	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.	BRCA1 BRCA2	1.30e-05	2	126	2	11377596
Pubmed	BRCA mutations and risk of prostate cancer in Ashkenazi Jews.	BRCA1 BRCA2	1.30e-05	2	126	2	15131025
Pubmed	Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.	BRCA1 BRCA2	1.30e-05	2	126	2	20033483
Pubmed	Health survey and assessment of the polymorphisms BRCA1/P871L, BRCA1/Q356R, and BRCA2/N372H in female gas station workers in Rio de Janeiro.	BRCA1 BRCA2	1.30e-05	2	126	2	28862356
Pubmed	BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.	BRCA1 BRCA2	1.30e-05	2	126	2	22425665
Pubmed	BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.	BRCA1 BRCA2	1.30e-05	2	126	2	18752448
Pubmed	Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.	BRCA1 BRCA2	1.30e-05	2	126	2	22425664
Pubmed	Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.	BRCA1 BRCA2	1.30e-05	2	126	2	22970155
Pubmed	Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.	BRCA1 BRCA2	1.30e-05	2	126	2	34304065
Pubmed	Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India.	BRCA1 BRCA2	1.30e-05	2	126	2	26625823
Pubmed	Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	26852015
Pubmed	Meta-analysis of BRCA1 and BRCA2 penetrance.	BRCA1 BRCA2	1.30e-05	2	126	2	17416853
Pubmed	Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.	BRCA1 BRCA2	1.30e-05	2	126	2	18175183
Pubmed	Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients.	BRCA1 BRCA2	1.30e-05	2	126	2	38057686
Pubmed	Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.	BRCA1 BRCA2	1.30e-05	2	126	2	27914478
Pubmed	BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.	BRCA1 BRCA2	1.30e-05	2	126	2	16455195
Pubmed	The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.	BRCA1 BRCA2	1.30e-05	2	126	2	23810788
Pubmed	Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.	BRCA1 BRCA2	1.30e-05	2	126	2	29727326
Pubmed	Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.	BRCA1 BRCA2	1.30e-05	2	126	2	35871032
Pubmed	Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.	BRCA1 BRCA2	1.30e-05	2	126	2	22739995
Pubmed	The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.	BRCA1 BRCA2	1.30e-05	2	126	2	27794048
Pubmed	Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.	BRCA1 BRCA2	1.30e-05	2	126	2	20972632
Pubmed	BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.	BRCA1 BRCA2	1.30e-05	2	126	2	19499246
Pubmed	Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.	BRCA1 BRCA2	1.30e-05	2	126	2	19656164
Pubmed	Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.	BRCA1 BRCA2	1.30e-05	2	126	2	15986445
Pubmed	Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	18165636
Pubmed	Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.	BRCA1 BRCA2	1.30e-05	2	126	2	23615136
Pubmed	Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.	BRCA1 BRCA2	1.30e-05	2	126	2	29982601
Pubmed	Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.30e-05	2	126	2	28343309
Pubmed	BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.	BRCA1 BRCA2	1.30e-05	2	126	2	17925560
Pubmed	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	27601588
Pubmed	Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.30e-05	2	126	2	23918944
Pubmed	Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.	BRCA1 BRCA2	1.30e-05	2	126	2	33558422
Pubmed	Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.	BRCA1 BRCA2	1.30e-05	2	126	2	30430339
Pubmed	Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.	BRCA1 BRCA2	1.30e-05	2	126	2	33534430
Pubmed	BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?	BRCA1 BRCA2	1.30e-05	2	126	2	34137566
Pubmed	BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.	BRCA1 BRCA2	1.30e-05	2	126	2	33918338
Pubmed	53BP1, a mediator of the DNA damage checkpoint.	BRCA1 TP53BP1	1.30e-05	2	126	2	12364621
Pubmed	Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.	BRCA1 BRCA2	1.30e-05	2	126	2	26181175
Pubmed	Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.	BRCA1 BRCA2	1.30e-05	2	126	2	14517958
Pubmed	Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.	BRCA1 BRCA2	1.30e-05	2	126	2	18559571
Pubmed	BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.	BRCA1 BRCA2	1.30e-05	2	126	2	27225819
Pubmed	BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.	BRCA1 BRCA2	1.30e-05	2	126	2	18559594
Pubmed	Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.	BRCA1 BRCA2	1.30e-05	2	126	2	31131559
Pubmed	The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.	BRCA1 BRCA2	1.30e-05	2	126	2	11981002
Pubmed	Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.	BRCA1 BRCA2	1.30e-05	2	126	2	29020660
Pubmed	An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.	BRCA1 BRCA2	1.30e-05	2	126	2	21934105
Pubmed	Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.	BRCA1 BRCA2	1.30e-05	2	126	2	28199346
Pubmed	Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.	BRCA1 BRCA2	1.30e-05	2	126	2	18092194
Pubmed	Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.	BRCA1 BRCA2	1.30e-05	2	126	2	16541324
Pubmed	Structure of the human plasma membrane Ca2+-ATPase 1 in complex with its obligatory subunit neuroplastin.	NPTN ATP2B1	1.30e-05	2	126	2	30190470
Pubmed	Investigating the relationship between BRCA1 and BRCA2 genes methylation profile and sperm DNA fragmentation in infertile men.	BRCA1 BRCA2	1.30e-05	2	126	2	31095775
Pubmed	Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.	BRCA1 BRCA2	1.30e-05	2	126	2	36385461
Pubmed	Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture?	BRCA1 BRCA2	1.30e-05	2	126	2	26254840
Pubmed	Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.	BRCA1 BRCA2	1.30e-05	2	126	2	19491894
Pubmed	Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	1.30e-05	2	126	2	29116468
Pubmed	BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.	BRCA1 BRCA2	1.30e-05	2	126	2	26026974
Pubmed	Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.	BRCA1 BRCA2	1.30e-05	2	126	2	24306927
Pubmed	[Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].	BRCA1 BRCA2	1.30e-05	2	126	2	15059511
Interaction	TERF2 interactions	EEFSEC BAG3 HMGN2 CHD8 REV3L PGAM1 BRCA1 BRCA2 MACROD2 ATP2B1 TP53BP1	6.56e-06	340	121	11	int:TERF2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF410 PEG3 ZNF223 ZNF230 ZNF836 ZNF394 ZNF608 ZNF544 ZNF827 ZNF846 ZNF483 ZNF616 ZNF81	1.95e-05	718	82	13	28
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRCA1 BRCA2 FANCI	9.70e-05	20	82	3	548
GeneFamily	Bisphosphoglycerate phosphatases	PGAM1 PGAM4	1.21e-04	4	82	2	1082
GeneFamily	Cholinergic receptors muscarinic	CHRM2 CHRM5	2.01e-04	5	82	2	180
GeneFamily	Ankyrin repeat domain containing	ANK3 ASB6 GLS ANKDD1A ANKIB1 MYO16	8.10e-04	242	82	6	403
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	CASP2 ITPR1 AKAP9 BRCA1 MYO16	1.39e-03	181	82	5	694
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SGTB CNOT10 TMTC3 WDTC1	1.85e-03	115	82	4	769
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 NRIP1 ATRX REV3L PNISR ITPR1 TDRD7 CEP170 JARID2 NEK1 DLC1 AKAP9 BRCA1 BRCA2 ATP2B1 TP53BP1	2.64e-06	856	123	16	M4500
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	NCOA2 FBXL17 PNISR ITPR1 AKAP9 MACROD2 ARHGAP18	7.77e-06	152	123	7	M39239
Coexpression	TBK1.DF_DN	NRIP1 DSC3 GALNT7 PNISR ESF1 NEK1 THBS1 AKAP9 ATP2B1	8.59e-06	286	123	9	M2864
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NRIP1 ATRX REV3L PNISR TDRD7 CEP170 JARID2 DLC1 AKAP9 BRCA1 ATP2B1	1.29e-05	466	123	11	M13522
Coexpression	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	IRF2BP2 NRIP1 ATRX NSD1 PNISR THBS1 ATP2B1	3.76e-05	194	123	7	M7313
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	UBA2 CEP43 NEK1 AKAP9 BRCA1 ZNF544 ZNF846 MAP7D2 PRR14L TP53BP1	3.97e-05	434	123	10	M15150
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	UBA2 CEP43 NEK1 ZNF836 AKAP9 BRCA1 MAP7D2 ZNF616 PRR14L TP53BP1	5.17e-05	448	123	10	MM1044
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NCOA2 FAM184A SGTB ATRX RBBP6 REV3L PNISR ESF1 NEK1 AKAP9 BRCA1 BRCA2 ANKIB1	2.39e-08	311	120	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NCOA2 RELCH FAM184A SGTB ATRX RBBP6 NPAS3 FBXL17 PNISR ESF1 NEK1 AKAP9 BRCA1 BRCA2 LRRC1 ANKIB1 MAP7D2 ZNF616 PRR14L	2.08e-07	831	120	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	NCOA2 FAM184A SGTB ATRX RBBP6 NPAS3 REV3L PNISR NSUN2 DMBX1 PEX26 ESF1 NEK1 AKAP9 BRCA1 BRCA2 ANKIB1 MAP7D2 ATP2B1 JHY	6.73e-07	989	120	20	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100	ATRX CHD8 PNISR ZNF616	6.56e-06	22	120	4	gudmap_developingGonad_e16.5_epididymis_100_k3
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000	USP53 IRF2BP2 NRIP1 RELCH FAM184A ANK3 ATRX REV3L PNISR ZC3H6 ITPR1 THBS1 AKAP9 GLS ANKIB1 CNDP1	7.53e-06	774	120	16	gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000	IRF2BP2 NRIP1 RELCH ANK3 ATRX REV3L PNISR ITPR1 THBS1 AKAP9 ANKIB1	9.37e-06	375	120	11	gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274	IRF2BP2 PEG3 NPAS3 PNISR ZC3H6 PPM1A CEP170 GLS LRRC1	1.53e-05	256	120	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	IRF2BP2 RELCH ANK3 ATRX REV3L THBS1 AKAP9 ANKIB1	1.90e-05	201	120	8	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	USP53 NRIP1 ATRX CHD8 PNISR ZNF616 ATP2B1	2.33e-05	150	120	7	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	USP53 NRIP1 RELCH ATRX PEG3 CHD8 PNISR JMJD1C ESF1 BRCA1 BRCA2 MACROD2 MAP7D2 ZNF616 PARP12	3.24e-05	776	120	15	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200	NRIP1 ATRX CHD8 PNISR ZNF616	3.34e-05	65	120	5	gudmap_developingGonad_e12.5_ovary_k2_200
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500	USP53 NRIP1 ATRX CHD8 PNISR ZNF616	3.62e-05	109	120	6	gudmap_developingGonad_e16.5_ovary_500_k5
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	LUZP4 RELCH ZC3H6 TDRD7 BRCA2 MAP7D2	3.81e-05	110	120	6	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500	IRF2BP2 NRIP1 RELCH REV3L PNISR ZC3H6 AKAP9	3.97e-05	163	120	7	gudmap_developingKidney_e15.5_cortic collect duct_500_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	NRIP1 ATRX PEG3 CHD8 PNISR ZNF616 ATP2B1	4.46e-05	166	120	7	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	NRIP1 ATRX PEG3 CHD8 PNISR ZNF616 ATP2B1	4.46e-05	166	120	7	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200	NRIP1 ATRX CHD8 PNISR ZNF616	4.46e-05	69	120	5	gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200	NRIP1 ATRX PEG3 CHD8 PNISR ZNF616 ATP2B1	4.63e-05	167	120	7	gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	IRF2BP2 RELCH ANK3 ATRX NSD1 REV3L GALNT7 THBS1 AKAP9 ANKIB1	5.93e-05	379	120	10	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500	LUZP4 ZC3H6 TDRD7 NEK1 BRCA1 BRCA2 FANCI MACROD2 MAP7D2 PARP12	6.76e-05	385	120	10	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200	NRIP1 ATRX PNISR ZNF616 ATP2B1	7.11e-05	76	120	5	gudmap_developingGonad_e16.5_epididymis_200_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	IRF2BP2 DSC3 PEG3 NPAS3 PNISR ZC3H6 PPM1A CEP170 THBS1 DLC1 TMTC3 GLS LRRC1 MACROD2 ANKIB1	7.52e-05	836	120	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	IRF2BP2 RELCH ATRX NSD1 REV3L NEK1 DLC1 AKAP9 ATP2B1	1.09e-04	330	120	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	NCOA2 RELCH ATRX NPAS3 REV3L PNISR PPM1A ITPR1 NEK1 DLC1 AKAP9 MACROD2 ANKIB1 ATP2B1	1.19e-04	772	120	14	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	IRF2BP2 RELCH ANK3 NSD1 REV3L ZC3H6 DLC1	1.19e-04	194	120	7	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	NCOA2 SGTB ATRX RBBP6 FBXL17 REV3L AKAP9 BRCA1 BRCA2 LRRC1 ANKIB1 ZNF616 PRR14L HEATR5B	1.32e-04	780	120	14	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	IRF2BP2 RELCH ATRX RBBP6 NPAS3 NSD1 REV3L ZC3H6 CEP170 NEK1 DLC1 AKAP9 GLRA2 ATP2B1	2.16e-04	818	120	14	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_200	ATRX CHD8 ZNF616	2.17e-04	21	120	3	gudmap_developingGonad_e14.5_ epididymis_200_k2
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500	USP53 ATRX CHD8 PNISR ZNF616	2.26e-04	97	120	5	gudmap_developingGonad_e18.5_ovary_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000	RELCH NPAS3 REV3L PNISR AKAP9 ANKIB1	2.28e-04	152	120	6	gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200	IRF2BP2 RELCH REV3L AKAP9	2.47e-04	54	120	4	gudmap_developingKidney_e15.5_cortic collect duct_200_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	IRF2BP2 RELCH ANK3 ATRX NSD1 REV3L ZC3H6 DLC1 AKAP9	2.52e-04	369	120	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	NCOA2 ATRX AKAP9 BRCA1 BRCA2 ANKIB1 ZNF616 HEATR5B	2.52e-04	291	120	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200	NRIP1 ATRX PEG3 CHD8 PNISR ZNF616	2.62e-04	156	120	6	gudmap_developingGonad_e12.5_ovary_200
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200	ATRX CHD8 PNISR ZNF616 ATP2B1 CNDP1	2.71e-04	157	120	6	gudmap_developingGonad_P2_epididymis_200
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500	USP53 ATRX CHD8 PNISR ZNF616	2.72e-04	101	120	5	gudmap_developingGonad_e14.5_ ovary_500_k1
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	USP53 NRIP1 ATRX CHD8 PNISR JMJD1C ZNF616	2.95e-04	225	120	7	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200	NRIP1 ATRX PEG3 CHD8 PNISR ZNF616	3.10e-04	161	120	6	gudmap_developingGonad_e11.5_ovary + mesonephros_200
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500	USP53 RELCH ATRX PEG3 CHD8 PNISR ESF1 MAP7D2 ZNF616	3.25e-04	382	120	9	gudmap_developingGonad_e14.5_ ovary_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	NCOA2 IRF2BP2 RELCH ANK3 REV3L NEK1 THBS1 DLC1 AKAP9	3.44e-04	385	120	9	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	USP53 NRIP1 ATRX PEG3 CHD8 PNISR ESF1 MAP7D2 ZNF616	3.57e-04	387	120	9	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500	IRF2BP2 NRIP1 RELCH REV3L PNISR ZC3H6 AKAP9 ANKIB1 CNDP1	3.78e-04	390	120	9	gudmap_developingKidney_e15.5_cortic collect duct_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200	NRIP1 ATRX CHD8 PNISR	3.95e-04	61	120	4	gudmap_developingGonad_e12.5_epididymis_k2_200
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200	ATRX CHD8 PNISR	4.16e-04	26	120	3	gudmap_developingGonad_e18.5_ovary_200_k3
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200	NRIP1 PNISR ZNF616 ATP2B1	4.74e-04	64	120	4	gudmap_developingGonad_e18.5_epididymis_200_k5
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	USP53 NRIP1 ATRX PEG3 CHD8 PNISR ESF1 ZNF616 ATP2B1	4.79e-04	403	120	9	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	PEG3 PNISR ZC3H6 PPM1A CEP170 DLC1 TMTC3 GLS MACROD2 ANKIB1	4.86e-04	492	120	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500	ATRX CHD8 PNISR ZNF616	5.03e-04	65	120	4	gudmap_developingGonad_P2_ovary_500_k2
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	NRIP1 ATRX CHD8 PNISR JMJD1C PPM1A CEP170 ZNF616	5.05e-04	323	120	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500	IRF2BP2 RELCH ANK3 REV3L AKAP9	5.36e-04	117	120	5	gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	RELCH ANK3 ATRX NSD1 REV3L GALNT7 NEK1 AKAP9	6.93e-04	339	120	8	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	LUZP4 RELCH ZC3H6 ESF1 TDRD7 NEK1 BRCA1 BRCA2 FANCI ZNF483 MACROD2 MAP7D2 PARP12	7.52e-04	820	120	13	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATRX ESF1 AKAP9 BRCA1 BRCA2 MAP7D2	7.87e-04	192	120	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500	ZC3H6 NEK1 BRCA2 MACROD2 MAP7D2	8.35e-04	129	120	5	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000	RELCH REV3L PNISR PPM1A THBS1 ANKIB1	9.97e-04	201	120	6	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	NRIP1 ATRX PNISR JMJD1C PPM1A ZNF616 ATP2B1	1.01e-03	277	120	7	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000	RELCH REV3L PPM1A ITPR1 NEK1 AKAP9	1.05e-03	203	120	6	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100	NRIP1 PEG3 CHD8 ZNF616	1.05e-03	79	120	4	gudmap_developingGonad_e11.5_ovary + mesonephros_100
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	NRIP1 ATRX PNISR ZNF616 ATP2B1	1.06e-03	136	120	5	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	IRF2BP2 RELCH RBBP6 REV3L ZC3H6 DLC1	1.22e-03	209	120	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	USP53 NRIP1 ATRX CHD8 PNISR ZNF616	1.25e-03	210	120	6	gudmap_developingGonad_e18.5_ovary_1000_k2
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	MTIF3 NRIP1 ATRX RBBP6 REV3L GALNT7 LRRIQ1 AKAP9 TMTC3 ANKIB1	3.05e-10	199	127	10	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 ATRX COL6A6 PEG3 NSD1 REV3L AKAP9 ATP2B1	9.30e-08	195	127	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	MTIF3 NRIP1 ATRX RBBP6 GALNT7 CEP170 LRRIQ1 AKAP9	1.05e-07	198	127	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	USP53 MTIF3 NRIP1 ATRX GALNT7 THBS1 AKAP9 ANKIB1	1.09e-07	199	127	8	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DSPP UBR4 ITPR1 JARID2 THBS1 ARHGAP18 ATP2B1 MCEMP1	1.09e-07	199	127	8	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	CARMIL1 ITPR1 DLC1 GLS MACROD2 SPARCL1 PLS3	9.72e-07	183	127	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CARMIL1 ITPR1 DLC1 GLS MACROD2 SPARCL1 PLS3	9.72e-07	183	127	7	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CEP43 LRRIQ1 BRCA1 BCO2 BRCA2 FANCI LIAT1	1.25e-06	190	127	7	0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CEP43 LRRIQ1 BRCA1 BCO2 BRCA2 FANCI LIAT1	1.25e-06	190	127	7	05455775845f4ded5c27e7b83242078d23162aaf
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAM184A ANK3 ZBBX CFAP54 BCO2 ZNF608 SPARCL1	1.39e-06	193	127	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CNOT10 CEP43 LRRIQ1 BCO2 BRCA2 FANCI LIAT1	1.44e-06	194	127	7	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 ATRX COL6A6 PEG3 REV3L AKAP9 ATP2B1	1.49e-06	195	127	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x5'-Liver-Lymphocytic_T_CD4\|Liver / Manually curated celltypes from each tissue	CASS4 FAM184A ANK3 JMJD1C CD3E TRAT1 GLS	1.59e-06	197	127	7	4891111894b741555f549deec6af8006376d9358
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	IRF2BP2 NRIP1 RBBP6 GALNT7 LRRIQ1 AKAP9 ARHGAP18	1.70e-06	199	127	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	USP53 MTIF3 NRIP1 ATRX GALNT7 AKAP9 ANKIB1	1.70e-06	199	127	7	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	USP53 MTIF3 ATRX REV3L GALNT7 AKAP9 TMTC3	1.70e-06	199	127	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A6 REV3L THBS1 FBN1 AKAP9 SPARCL1 MYO16	1.76e-06	200	127	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP53 WNT8B PEX26 BCO2 ZNF827 MTERF2	9.76e-06	171	127	6	d1e87478d8c0329e662849823f5c7604f20e1b1a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	USP53 LRRC9 CFAP54 LRRIQ1 BCO2 JHY	9.76e-06	171	127	6	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNOT10 KLHL31 CD3E ZNF394 ZNF483 JHY	1.15e-05	176	127	6	ac83a6cd4bcbb9ca1fc02a9fbd9d9629ef1df8ca
ToppCell	facs-GAT-Fat-3m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 ZBBX LRRIQ1 LIAT1 JHY CNDP1	1.35e-05	181	127	6	e97cbaafb93fdbee8e3cf4a06e6bcf121d941403
ToppCell	facs-GAT-Fat-3m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 ZBBX LRRIQ1 LIAT1 JHY CNDP1	1.35e-05	181	127	6	11cb84528f7ca084f0a92eda4f2e18e63a428fe9
ToppCell	facs-GAT-Fat-3m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCTE1 ZBBX LRRIQ1 LIAT1 JHY CNDP1	1.35e-05	181	127	6	5ffeca29e4d31a20c110d27af128ed024a79ad56
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1\|bone_marrow / Manually curated celltypes from each tissue	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	1.35e-05	181	127	6	ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Pvalb_(Layer_5a)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TOPAZ1 WNT8B CD3E MCEMP1	1.37e-05	51	127	4	28d6b12c44ad308560931d275e0dd0243a555bf3
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCTE1 ZBBX CFAP54 LRRIQ1 LIAT1 JHY	1.48e-05	184	127	6	797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCTE1 ZBBX CFAP54 LRRIQ1 LIAT1 JHY	1.48e-05	184	127	6	77d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPAS3 RGS12 ZNF608 GLRA2 ARHGAP18 PLS3	1.53e-05	185	127	6	027020754dbf71b0034791f9a34ae795e3b85f81
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX NSD1 JMJD1C THBS1 ZNF608 ATP2B1	1.53e-05	185	127	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|bone_marrow / Manually curated celltypes from each tissue	FAM184A ANK3 BAG3 CD3E TRAT1 ZNF483	1.57e-05	186	127	6	5108d9b7a081876ca34594b110d58df56063f542
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	FAM184A ANK3 TDRD7 CD3E TRAT1 PARP12	1.67e-05	188	127	6	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEP43 LRRIQ1 BRCA1 BCO2 BRCA2 FANCI	1.77e-05	190	127	6	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR2A CARMIL1 ITPR1 ZBBX GLS ATP2B1	1.77e-05	190	127	6	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	1.83e-05	191	127	6	b85a0978dc1e8af4f49423f56dcfd52efce09ed1
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT7 ANK3 DSC3 ZNF608 MACROD2 PLS3	1.88e-05	192	127	6	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	DSC3 COL6A6 PEG3 TGM5 FBN1 SPARCL1	1.94e-05	193	127	6	09de51f8ac509e03d480ed3dc9dfe7e7defc59cb
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	ANK3 NPAS3 REV3L RGS12 AKAP9 PLS3	1.99e-05	194	127	6	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	ANK3 NPAS3 REV3L RGS12 AKAP9 PLS3	1.99e-05	194	127	6	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	1.99e-05	194	127	6	e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CNOT10 REV3L CEP43 BRCA1 BRCA2 FANCI	1.99e-05	194	127	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	facs-Thymus-Epithelium-24m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT7 PEG3 TGM5 SPARCL1 PLS3 HR	2.05e-05	195	127	6	cc89261bb091ef978bd73cffc68ccdd00a8786d1
ToppCell	mild-Lymphocytic-Prol._cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.05e-05	195	127	6	9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCell	mild-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.11e-05	196	127	6	b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DSPP JARID2 THBS1 ARHGAP18 ATP2B1 MCEMP1	2.11e-05	196	127	6	a44a648bf209ce037bfc7b3adfcb220aab60728c
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM184A ZBBX LRRC9 CFAP54 LRRIQ1 AKAP9	2.17e-05	197	127	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	2.17e-05	197	127	6	2a89a724e8c15a5bb167fdad7eed31444d8c3d68
ToppCell	(3)_Chondrocytes-(30)_Chondro\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	USP53 DSC3 PEG3 KCTD4 THBS1 SPARCL1	2.17e-05	197	127	6	a07ab2564ca7d577fd47f444dd7b0c25556e9fc4
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA3 HMGN2 CD3E BRCA1 BRCA2 FANCI	2.24e-05	198	127	6	d484ac79d6cd29f1d9c192d126c2099f737d5320
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA3 HMGN2 CD3E BRCA1 BRCA2 FANCI	2.24e-05	198	127	6	ac0be1666456cfa8d68588b187d65008e6d5c0e2
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	2.24e-05	198	127	6	428182c71f009906c581e02257e545ea5fb99650
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 CD3E BRCA1 TRAT1 FANCI	2.24e-05	198	127	6	55ea8c9d2154ded74c7b851735b24c95bae01de4
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1\|bone_marrow / Manually curated celltypes from each tissue	HMGN2 HNRNPAB BRCA1 BRCA2 FANCI MCEMP1	2.24e-05	198	127	6	5c92687b853ebb00960adbef6552f9d460bc6886
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	TCTE1 ZBBX LRRC9 CFAP54 SLC13A4 LRRIQ1	2.24e-05	198	127	6	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 CD3E BRCA1 TRAT1 FANCI	2.24e-05	198	127	6	fc7d8b8e710eedd6cfc1e5393f0c23feac283807
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ATRX PNISR CEP170 AKAP9 ZNF608 PLS3	2.24e-05	198	127	6	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 CD3E BRCA1 TRAT1 FANCI	2.24e-05	198	127	6	ddec07c7bc26d35f155537d907b46e2cb5b55b5f
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	2.30e-05	199	127	6	13ff6c26ebcc663ef8e5559ab9be99dab848abe7
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RELCH ANK3 ATRX PNISR AKAP9 GLS	2.30e-05	199	127	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	4394dcd1809f49e9bada8f5e115d5123356eae3e
ToppCell	remission-T/NK_proliferative\|remission / disease stage, cell group and cell class	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	303a5fc43a48b05b6f2060d99eef4adc36f8d4e3
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	c0ea391bb347b99b94b5d7f02612ede938986745
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	96af1f289552f38f2dfa181192eb3276f4c7d70b
ToppCell	remission-T/NK_proliferative\|World / disease stage, cell group and cell class	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	f305f3a454b7d2170429bad087480ccccca19acd
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSC3 COL6A6 PEG3 CHRM2 SPARCL1 PLS3	2.30e-05	199	127	6	83383d9ae4f501754fd3da0215ce6f0e3c70562c
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease group, lineage and cell class	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	893b78c661c529db07a5fcc3124d9b3d0f270fa5
ToppCell	COVID-19_Convalescent-T/NK_proliferative\|COVID-19_Convalescent / Disease condition and Cell class	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	c608d953b852b67a4e36bd63d45f0deec3eefbd9
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	5b18e18ddbf4bd53aa0d574d23092cb96da7f400
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	6df65f4c2f9a125e0c7c4f597fefc05a97fc8831
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.30e-05	199	127	6	cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 RBBP6 HMGN2 NEK1 NDUFAF1 BRCA2	2.37e-05	200	127	6	d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TCTE1 FAM184A ZBBX LRRC9 CFAP54 LRRIQ1	2.37e-05	200	127	6	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	NS-moderate-d_07-13-Lymphoid-NKT-proliferating\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CDCA3 HMGN2 CD3E BRCA1 BRCA2 FANCI	2.37e-05	200	127	6	87e293c0882e2754756a2210a6c04723dc89f81b
ToppCell	(0)_NK_cells-(0)_NK_dividing\|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CDCA3 ATRX HMGN2 BRCA1 BRCA2 FANCI	2.37e-05	200	127	6	1a630bb327070ffcb111ec36bd8fd4be3627ca2a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 RBBP6 HMGN2 NEK1 NDUFAF1 BRCA2	2.37e-05	200	127	6	3d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HTR2A DSC3 COL6A6 SBSN FBN1 PLS3	2.37e-05	200	127	6	93c1db92e0e456101f7895867fc8a1fe45298347
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.37e-05	200	127	6	5d11a2c0021805e78d97dc1638bf73ca1faede66
ToppCell	Parenchyma_COVID-19-Stromal-TX-Mesothelial-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	HTR2A DSC3 COL6A6 SBSN FBN1 PLS3	2.37e-05	200	127	6	3be373e9a30e19334e4709e2819fb83cc777d104
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDCA3 HMGN2 BRCA1 BRCA2 FANCI MCEMP1	2.37e-05	200	127	6	5e1b38e2aa8901bfb2623249f7b6302e97d56ace
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A6 REV3L THBS1 FBN1 AKAP9 MYO16	2.37e-05	200	127	6	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease, condition lineage and cell class	CDCA3 HMGN2 HNRNPAB BRCA1 BRCA2 FANCI	2.37e-05	200	127	6	00538c4cbab5da00b3a366717d38a3ba5cfe3f65
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 USP53 COL6A6 THBS1 FBN1 SPARCL1	2.37e-05	200	127	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HTR2A DSC3 COL6A6 SBSN FBN1 PLS3	2.37e-05	200	127	6	46d0ae385e67030bfaf7062bb6b43da5db05b33a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CASS4 COL6A6 FBN1 SPARCL1 ATP2B1 MYO16	2.37e-05	200	127	6	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	USP53 MTIF3 NRIP1 RBBP6 AKAP9	4.75e-05	138	127	5	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF223 CD3E FBN1 TRAT1 MYO16	6.01e-05	145	127	5	42dd36c1bc2c43cfea7196e89f901e4ea2a403c7
ToppCell	Ciliated_cells-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	TCTE1 ZBBX LRRC9 CFAP54 LRRIQ1	6.84e-05	149	127	5	6399c5a2f06d79f020dece252526f1c0c110d569
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	KRT7 ZBBX CFAP54 LRRIQ1 MACROD2	7.29e-05	151	127	5	8216462e723fec2797387929dde095370947e10a
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCTE1 ZBBX LRRC9 CFAP54 LRRIQ1	7.29e-05	151	127	5	81cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCTE1 ZBBX LRRC9 CFAP54 LRRIQ1	7.29e-05	151	127	5	9cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCell	PBMC-Control-cDC_2\|Control / Compartment, Disease Groups and Clusters	CD3E TRAT1 ZNF483 MYO16 CNDP1	7.75e-05	153	127	5	4ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCTE1 ZBBX LRRC9 CFAP54 LRRIQ1	8.00e-05	154	127	5	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCTE1 ZBBX LRRC9 CFAP54 LRRIQ1	8.00e-05	154	127	5	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NPAS3 RGS12 ZNF608 GLRA2 CNDP1	8.25e-05	155	127	5	105d59d8a1bb8cb37eef2c1767d737b2108ac7c5
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	SGTB ANK3 CD3E TRAT1 ZNF483	8.76e-05	157	127	5	23879e65a6acc33d9aad096cd23604a77b0ac9c2
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZBBX CFAP54 LRRIQ1 BRCA2 FANCI	8.76e-05	157	127	5	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	NCOA2 ANK3 JARID2 TRAT1 MACROD2	9.58e-05	160	127	5	8aaf6ac4f33ea291387fdbf9ff1a91d559391774
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 CD3E TRAT1 ZNF827 FANCI	9.86e-05	161	127	5	140b3c7077947c541cff54f6754e2df968345f4d
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4\|Lung / Manually curated celltypes from each tissue	TCTE1 FAM184A ANK3 LRRIQ1 TRAT1	1.02e-04	162	127	5	91cc14aec8d580cf97a1929bc1acb00fcbcdb57a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF410 FAM184A ANK3 ZNF608 MACROD2	1.14e-04	166	127	5	c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA3 BRCA1 BRCA2 FANCI CNDP1	1.17e-04	167	127	5	50c29ea660bf07b890e4ac1a1985d0761d863dee
Drug	Succimer	NCOA2 NRIP1 ANK3 ATRX RBBP6 NSD1 REV3L GALNT7 PNISR JMJD1C TGM5 ITPR1 CEP170 ZNF836 THBS1 ZNF394 AKAP9 BRCA1 BCO2 BRCA2 ARHGAP18 ATP2B1 PARP12	3.04e-07	1264	124	23	ctd:D004113
Drug	Magnetite Nanoparticles	NCOA2 NRIP1 ANK3 ATRX RBBP6 NSD1 REV3L GALNT7 PNISR JMJD1C TGM5 ITPR1 CEP170 ZNF836 THBS1 ZNF394 AKAP9 BRCA1 BCO2 BRCA2 ARHGAP18 ATP2B1 PARP12	5.68e-07	1310	124	23	ctd:D058185
Drug	Paroxetine	HTR2A CHRM2 CHRM5	8.66e-06	8	124	3	DB00715
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A	USP53 NPAS3 CASP2 RGS12 DLC1 AKAP9 GLRA2 GLS	1.23e-05	196	124	8	2263_UP
Drug	Rilapinum	HTR2A CHRM2 CHRM5	1.29e-05	9	124	3	CID006446980
Drug	Promethazine	HTR2A CHRM2 CHRM5	1.84e-05	10	124	3	DB01069
Drug	tenilapine	HTR2A CHRM2 CHRM5	1.84e-05	10	124	3	CID006450478
Drug	Imipramine	HTR2A CHRM2 CHRM5	2.52e-05	11	124	3	DB00458
Drug	dimethyl-W84	CHRM2 CHRM5	2.94e-05	2	124	2	ctd:C113497
Drug	Nortriptyline	HTR2A CHRM2 CHRM5	3.35e-05	12	124	3	DB00540
Drug	Chlorprothixene	HTR2A CHRM2 CHRM5	3.35e-05	12	124	3	DB01239
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 NRIP1 REV3L JARID2 AKAP9 LRRC1 ATP2B1	4.29e-05	171	124	7	7535_DN
Drug	Desipramine	HTR2A CHRM2 CHRM5	4.33e-05	13	124	3	DB01151
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	NCOA2 NRIP1 REV3L JMJD1C JARID2 LRRC1 ATP2B1	4.79e-05	174	124	7	7530_DN
Drug	propiomazine	HTR2A CHRM2 CHRM5	5.49e-05	14	124	3	CID000004940
Drug	Promazine	HTR2A CHRM2 CHRM5	5.49e-05	14	124	3	DB00420
Drug	Propiomazine	HTR2A CHRM2 CHRM5	5.49e-05	14	124	3	DB00777
Disease	Fanconi anemia (is_implicated_in)	BRCA1 BRCA2 FANCI	8.10e-06	10	122	3	DOID:13636 (is_implicated_in)
Disease	ductal carcinoma in situ (biomarker_via_orthology)	BRCA1 BRCA2	1.70e-05	2	122	2	DOID:0060074 (biomarker_via_orthology)
Disease	Hereditary site-specific ovarian cancer syndrome	BRCA1 BRCA2	1.70e-05	2	122	2	C4749652
Disease	fibromuscular dysplasia	FAM184A CARMIL1 ZNF827 ATP2B1	3.32e-05	44	122	4	EFO_1000938
Disease	Schizophrenia	NRIP1 HTR2A ANK3 NPAS3 CHRM2 CHRM5 RGS12 JARID2 NPTN THBS1 BRCA1 ARHGAP18 MYO16	7.70e-05	883	122	13	C0036341
Disease	prostate cancer (biomarker_via_orthology)	THBS1 BRCA2	1.01e-04	4	122	2	DOID:10283 (biomarker_via_orthology)
Disease	Hereditary breast ovarian cancer syndrome	BRCA1 BRCA2	1.01e-04	4	122	2	cv:C0677776
Disease	Fanconi Anemia	BRCA1 BRCA2 FANCI	1.48e-04	25	122	3	C0015625
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA1 BRCA2	1.68e-04	5	122	2	DOID:5683 (is_implicated_in)
Disease	MYELODYSPLASTIC SYNDROME	ATRX BRCA1 BRCA2 FANCI	1.74e-04	67	122	4	C3463824
Disease	lung carcinoma	COL6A6 CARMIL1 CEP43 TGM5 CEP170 CD3E DLC1 BRCA2 TP53BP1	1.84e-04	482	122	9	EFO_0001071
Disease	Miller Dieker syndrome	BRCA1 BRCA2 FANCI	2.33e-04	29	122	3	C0265219
Disease	SPARC-like protein 1 measurement	DSPP SPARCL1	2.52e-04	6	122	2	EFO_0008289
Disease	Adult only	BRCA1 BRCA2	2.52e-04	6	122	2	C3842001
Disease	spontaneous coronary artery dissection	FBN1 ZNF827 ATP2B1	2.85e-04	31	122	3	EFO_0010820
Disease	schizophrenia (is_implicated_in)	HTR2A ANK3 CHRM2 ARHGAP18	3.13e-04	78	122	4	DOID:5419 (is_implicated_in)
Disease	Autism Spectrum Disorders	CHD8 NSUN2 JARID2 GLRA2	4.35e-04	85	122	4	C1510586
Disease	bone measurement	MEI4 ZNF483	4.67e-04	8	122	2	EFO_0004512
Disease	colorectal carcinoma (is_marker_for)	NCOA2 BRCA1 BRCA2	4.84e-04	37	122	3	DOID:0080199 (is_marker_for)
Disease	FEV/FEC ratio	EEFSEC FAM184A DSPP BAG3 NSD1 FBXL17 JMJD1C ITPR1 NPTN FBN1 DLC1 ANKDD1A ATP2B1 MYO16	5.64e-04	1228	122	14	EFO_0004713
Disease	Pancreatic carcinoma, familial	BRCA1 BRCA2	5.99e-04	9	122	2	C2931038
Disease	Adenoid Cystic Carcinoma	ATRX NSD1 JMJD1C BRCA1	8.03e-04	100	122	4	C0010606
Disease	plasma beta-amyloid 1-42 measurement	ANK3 FBXL17	1.28e-03	13	122	2	EFO_0005660
Disease	Benign tumor of pancreas	BRCA1 BRCA2	1.28e-03	13	122	2	C0347284
Disease	Fanconi anemia	BRCA2 FANCI	1.49e-03	14	122	2	cv:C0015625
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA1 BRCA2	1.49e-03	14	122	2	C0677776
Disease	free cholesterol to total lipids in medium VLDL percentage	JMJD1C RGS12 TP53BP1	1.71e-03	57	122	3	EFO_0022284
Disease	liver volume	JMJD1C TP53BP1	1.72e-03	15	122	2	EFO_0600048
Disease	major depressive disorder (is_implicated_in)	HTR2A CHRM2	2.21e-03	17	122	2	DOID:1470 (is_implicated_in)
Disease	cortical thickness	NCOA2 IRF2BP2 JMJD1C THBS1 FBN1 DLC1 LRRIQ1 PROX2 GLS MACROD2 ARHGAP18 MYO16	2.25e-03	1113	122	12	EFO_0004840
Disease	triglycerides to total lipids in medium VLDL percentage	JMJD1C RGS12 TP53BP1	2.29e-03	63	122	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	JMJD1C RGS12 TP53BP1	2.29e-03	63	122	3	EFO_0022239
Disease	ovarian neoplasm	DLC1 BRCA1 BRCA2 TP53BP1	2.36e-03	134	122	4	C0919267
Disease	Bone marrow hypocellularity	BRCA2 FANCI	2.48e-03	18	122	2	C1855710
Disease	Malignant neoplasm of ovary	DLC1 BRCA1 BRCA2 TP53BP1	2.56e-03	137	122	4	C1140680
Disease	Epstein-Barr virus infection	FAM184A DLC1 MACROD2	2.61e-03	66	122	3	EFO_0000769
Disease	Intellectual Disability	CASP2 NSD1 CHD8 NSUN2 BRCA1 SMARCC2 CNDP1	2.63e-03	447	122	7	C3714756
Disease	Profound Mental Retardation	CASP2 NSD1 CHD8 CNDP1	2.70e-03	139	122	4	C0020796
Disease	Mental Retardation, Psychosocial	CASP2 NSD1 CHD8 CNDP1	2.70e-03	139	122	4	C0025363
Disease	Mental deficiency	CASP2 NSD1 CHD8 CNDP1	2.70e-03	139	122	4	C0917816
Disease	radiation-induced disorder	DLC1 MACROD2 MYO16	2.72e-03	67	122	3	EFO_0009565
Disease	Pancreatic carcinoma	BRCA1 BRCA2	2.77e-03	19	122	2	C0235974
Disease	synophrys measurement	DMBX1 LRRIQ1 ZNF608	2.84e-03	68	122	3	EFO_0007906
Disease	Adenocarcinoma of prostate	BRCA1 BRCA2	3.07e-03	20	122	2	C0007112
Disease	BREAST CANCER	BRCA1 BRCA2	3.38e-03	21	122	2	114480
Disease	systemising measurement	ZNF223 CEP170	3.38e-03	21	122	2	EFO_0010221
Disease	mean platelet volume	LUZP4 COL6A6 CARMIL1 JMJD1C RGS12 NARF GLS ANKDD1A MACROD2 ARHGAP18 PLS3	3.42e-03	1020	122	11	EFO_0004584
Disease	juvenile idiopathic arthritis	CARMIL1 JMJD1C SLC13A4	3.61e-03	74	122	3	EFO_0002609
Disease	age at voice drop	ZNF483 JHY	3.71e-03	22	122	2	EFO_0007888
Disease	intellectual disability (implicated_via_orthology)	ATRX UBR4 NSUN2	3.75e-03	75	122	3	DOID:1059 (implicated_via_orthology)
Disease	Bipolar Disorder	HTR2A ANK3 NPAS3 PGAM1 CHRM2 ITPR1 BRCA2	3.76e-03	477	122	7	C0005586
Disease	frailty measurement	ANK3 HR	4.05e-03	23	122	2	EFO_0009885

Protein segments in the cluster

Peptide	Gene	Start	Entry
TNGKPEEKNHEAGTS	CEP170	196	Q5SW79
GGKENTASSKQAHAV	AKAP9	1466	Q99996
NIKNDNGGSSLTFEH	CFAP54	1716	Q96N23
AENGKTKELQNHSGL	CHD8	1511	Q9HCK8
LEKAKEVSENSAGHN	CASS4	366	Q9NQ75
VALGKQHSEEASKDN	HTR2A	446	P28223
KHGGDLFAENENKDT	ANKIB1	166	Q9P2G1
KDSSNNSKGQEGQDH	DSPP	271	Q9NZW4
NSKGQEGQDHGKEDD	DSPP	276	Q9NZW4
NNGNDDNDKSDSGKG	DSPP	531	Q9NZW4
SDDGLEHNKIQNGKA	CHRM2	251	P08172
GADVNAADKHGKTAL	ASB6	161	Q9NWX5
KAGEGLDQVHNSAAK	BCO2	391	Q9BYV7
QDHSASVNKGQEKAE	FAM184A	206	Q8NB25
NSLKEANHDGDFGIT	ATP2B1	16	P20020
AGEQLEGLKHAQDSD	CDCA3	51	Q99618
KHGKAENAFTVGTDN	C17orf113	56	A0A1B0GUU1
KEGSDTAGNAHKNSE	CPXCR1	6	Q8N123
STHNSEKKGDGTQNS	NSD1	961	Q96L73
DSDNGKENQTVHKNL	GLS	651	O94925
GTNAEEEKNKRQNHS	LUZP4	41	Q9P127
GKGHSDGSNNSKVTD	LRRC9	306	Q6ZRR7
HATEDLENNGSKKDG	NSUN2	486	Q08J23
QHPDVNSSDKGKNTD	RELCH	421	Q9P260
NEEGTASEHGGQNKE	FANCI	1306	Q9NVI1
DEGGQALAHALQTNK	TCTE1	376	Q5JU00
GGEDQNDARNQAKHA	KLHL31	371	Q9H511
DSGLNVNKERGHKDQ	JHY	461	Q6NUN7
GEKKEANHSEGQEGS	NEK1	581	Q96PY6
EKHAAAAGGKAENSA	MAP7D2	371	Q96T17
ASGENEHKKTEEGNN	ITPR1	1156	Q14643
KFETLQAQAGKHGDD	KRT7	286	P08729
KHFLSSGGNVNEKND	MYO16	206	Q9Y6X6
TSKINGEEGKPHNNE	JMJD1C	406	Q15652
PHNNEKAGEETLKNS	JMJD1C	416	Q15652
NASSGNDHLNMEKEK	JMJD1C	581	Q15652
VTAGKHGDNLRDTKN	KRT79	346	Q5XKE5
ENGDAKTDQAQKAEG	HMGN2	71	P05204
NKDVDSGQHDEQKGP	HR	456	O43593
NHKGSENKTDLDNSI	ESF1	121	Q9H501
DTLNKDHGNDKESNV	MTIF3	261	Q9H2K0
LVKSGNLTEDDKHNN	PLS3	571	P13797
QKQEHSGSEEAQKPN	PEX26	206	Q7Z412
GKHNSLEDTDQGKNC	KCTD4	16	Q8WVF5
AVDKKSAGHNEEDQN	NRIP1	36	P48552
TGLNKAETAAKHGEA	PGAM4	96	Q8N0Y7
SHNGNELVESNEKGE	PEG3	846	Q9GZU2
NAAKGLDSNKNEVNH	LRRC1	501	Q9BTT6
NNKHLSLEDISNDKG	LRRIQ1	406	Q96JM4
KHVLEARNNKESSGN	RBBP6	1571	Q7Z6E9
DGHLANLNGSKKEFE	MTERF2	346	Q49AM1
DGQAATLKFQAGKHN	PARP12	421	Q9H0J9
DHQQGTSKDLSGAEK	PROX2	191	Q3B8N5
SGHENKTKGDSIQNE	BRCA1	551	P38398
DNQGHKNLKTSQEGS	ATRX	861	P46100
GENKSGAADIAASQH	HEATR5B	401	Q9P2D3
NGHFKISTDKETNEG	DSC3	401	Q14574
NRQKQNIDGHGSDDS	BRCA2	2431	P51587
NIDGHGSDDSKNKIN	BRCA2	2436	P51587
GSDDSKNKINDNEIH	BRCA2	2441	P51587
SGQKAGDKKANDEAN	CEP43	186	O95684
GHSDENKATGQGREN	LINC00322	171	Q6ZN03
TSHGADANLEAGNVK	FBN1	21	P35555
EQLQKQKEAEGSHGE	DMBX1	136	Q8NFW5
AKNEQEHHAGGDSQK	GALNT7	91	Q86SF2
QKVHVGNQDKLTDEG	FBXL17	441	Q9UF56
SQRKTEGDLQGDHQK	NDUFAF1	51	Q9Y375
NQKELESNGSGKDNE	ANK3	3356	Q12955
HNDKNIGGDEDDKNI	CD3E	61	P07766
NEKGANFHDVTTDNK	GLRA2	136	P23416
DKKQGVSAKNQGAHD	MCEMP1	21	Q8IX19
EQKQRSSSKDGHQGS	CARMIL1	1341	Q5VZK9
KKNAGNAEDPHTETQ	BAG3	536	O95817
KKNDGENQEHSLGTE	SLC13A4	436	Q9UKG4
AEKLGQGVNHAADQA	SBSN	491	Q6UWP8
QGVNHAADQAGKEVE	SBSN	496	Q6UWP8
VADNAGGSHASKDAN	IRF2BP2	431	Q7Z5L9
DRGVDQQDGKNHAGS	CASP2	326	P42575
TGLNKAETAAKHGEA	PGAM1	96	P18669
GESHDADKLNATAKA	COL6A6	921	A6NMZ7
GTKTDNNEGHKNGNV	PRR14L	206	Q5THK1
NNEGHKNGNVSKDLS	PRR14L	211	Q5THK1
KNSQKRQHAEGIAGS	JARID2	41	Q92833
HPDGQENDSTKNEIK	MACROD2	326	A1Z1Q3
GNTSSIGHDDQEIKK	MEI4	331	A8MW99
GDQINASKNEEDAGK	HNRNPAB	56	Q99729
GSGKGDDKHQSQSLK	LIAT1	96	Q6ZQX7
EEKNEANHLGGQRDS	MARCOL	41	A0A1B0GUY1
KKDGVANAEATNGKH	SLC9A5	671	Q14940
GETEANNHKKLSEFG	UBA2	496	Q9UBT2
AGEAGAQASSKHQKR	NPAS3	586	Q8IXF0
DKIQKDAGQAHGDND	TDRD7	411	Q8NHU6
ENGLEKSGFSQHQNK	DLC1	291	Q96QB1
GNKGEQTKNPDLHED	SMARCC2	401	Q8TAQ2
KADGNQETNNGCHKV	CHRM5	386	P08912
SGCDHNVKDKEGNTA	ANKDD1A	181	Q495B1
GAVDDGEHSQNEKIN	CNDP1	471	Q96KN2
ETGNNNNKDGSNHKA	CNOT10	191	Q9H9A5
NNKDGSNHKAESGAL	CNOT10	196	Q9H9A5
ADGQSRLHDSKGQTK	NCOA2	626	Q15596
HKSDNLKENGFGDQA	USP53	386	Q70EK8
NLHNNEAGRKAVKGT	WNT8B	161	Q93098
NEKGDLLASGSDDQH	WDTC1	56	Q8N5D0
NDEADKKAGQATEGH	EEFSEC	391	P57772
NQADHDKDGKGDACD	THBS1	881	P07996
NKNGSIEGEDSKNNE	ZNF394	271	Q53GI3
NAGTNVKHKRGDDDD	ZC3H6	811	P61129
HIGEKTSEDNQSGKA	ZNF846	136	Q147U1
ENNLTGKRDQHSQGD	ZNF616	116	Q08AN1
QQKNHSGENPSKCED	ZNF223	446	Q9UK11
NSDSGIGNFHQEEKS	RGS12	421	O14924
DLNHSKNKVSSEGNE	REV3L	711	O60673
LDHITNNQDFKGSAG	PPM1A	76	P35813
GLKDQEDSDGHLSVN	SPARCL1	96	Q14515
QEGKTGLEAISNHKE	SPARCL1	296	Q14515
PGEHQEAKKAENSSN	SPARCL1	401	Q14515
KNAKTSSNGENVHLG	ZNF410	186	Q86VK4
TGHKRSENKNEGQDA	NPTN	241	Q9Y639
KQNTHFSDKDGDEQL	TRAT1	126	Q6PIZ9
GNSGFNEHLKENKVA	TP53BP1	76	Q12888
GKEQKLHQDTSSVGN	TGM5	411	O43548
DQTVGNSHAKAGEEA	ARHGAP18	21	Q8N392
KDDSDGSQKNKGGNN	ZNF827	981	Q17R98
KDGQEANNSAGKTIH	TOPAZ1	646	Q8N9V7
QNSAFINHEKNGADG	ZNF544	196	Q6NX49
DHLNKNEGLANGLSE	ZNF608	856	Q9ULD9
KDQQGDHNGENSSKC	ZNF230	436	Q9UIE0
SEEDHGNQGNSKGRV	ZNF483	271	Q8TF39
KIDDQRGNLSGNSHK	PNISR	641	Q8TF01
DVGKADQLKDEGNNH	SGTB	81	Q96EQ0
SNKQLGKNGDEETPH	TMTC3	871	Q6ZXV5
AAGIKNNSNGHQLKD	UBR4	4666	Q5T4S7
TGNHDDNKKQNLHAA	ZBBX	271	A8MT70
NGKRGQHSQEDVENK	ZNF836	121	Q6ZNA1
SNAAKNLDKTIGHGQ	ZNF81	211	P51508
KTQAGDKFGEHNECT	ZNF658B	101	Q4V348
GSQDAAHDLDTLKKN	DUSP19	76	Q8WTR2
AQENGEKGEFHKLAD	NARF	31	Q9UHQ1